Skip to main content
 

Mediwhale

Mediwhale

Mediwhale is an innovative retina-based AI company that autonomously assesses cardiovascular disease risk. With a simple eye scan using fundus cameras, the company’s AI algorithm analyzes the blood vessels in the retinal images and generates a future cardiovascular disease risk with comparable performance to a heart CT scan within a minute, providing a safe, affordable, and accessible solution at the point of care. Mediwhale also expands the coverage from cardiovascular disease to renal and metabolic diseases.

More News

  • AccurKardia Secures FDA 510(k) Clearance of and Launches AccurECG 2.0

  • Amplity joins Innovators’ Network at the American Heart Association’s Center for Health Technology & Innovation

  • Smarter Care or Risky Business? Evaluating AI in Health Care